Measure 1.3
Project
The project will consist of R&D work, followed by the implementation of production and sale on the veterinary market of a biphasic biomaterial for the regeneration of cartilage and bone defects, implemented under Measure 1.3 Research and development infrastructure in enterprises, Priority I Research and innovation, European Funds for Lubelskie Voivodeship 2021-2027 programme.
Project objective
The overarching aim of the project is to improve the company’s competitiveness on the market by implementing a new product with the working name “OsteoChondral Graft”, which is an innovative biomaterial. In addition, activities carried out under the project are in line with the objectives of Measure 1.3 Research and development infrastructure in enterprises, contributing to the implementation of Specific Objective 1 Developing and strengthening research and innovation capacities and the use of advanced technologies FEL 2021-2027, by increasing the importance of research and innovation in the socio-economic structure of the Lubelskie Voivodeship and the use of advanced technologies.
Planned results
The implementation will result in a new innovative product with the working name “OsteoChondral Graft”. The project will involve R&D work on the application of the new product in veterinary medicine and its implementation on the veterinary market. This project will be the starting point for further projects with the final goal of certifying the product as a medical device and commercialising it on the market for human applications.